Market Cap
$3.3B
CSTM
CONSTELLIUM SE
$24.66 ▲ +1.94%
Prev close $24.19Market cap$3.3B
ConsensusStrong Buy
12-mo target$35.51 (+45.6%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10) Materials & Mining
Snapshot
The big-picture read on CSTM right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (82%)
Insider Activity
$207.7K buy / $11.7M sell
Insider Net $
-$11.5M
SEC Reports
20
Price chart 30d -6.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 1, 2026 short_volume
Short Volume: CSTM — 55.8% short (0.3M / 0.6M)
Short: 316,558 | Exempt: 200 | TRF Vol: 567,557 | Short Ratio: 55.8% | Off-exchange volume (dark poo
Aug 3, 2026 Insider
Jul 10, 2026 SEC Deslarzes Jean-Christophe bought 1,490 shares
Director @ $27.24 ($40.6K)
Constellium SE filed a press release announcing a conference call for its Q2 2026 earnings, scheduled for July 29, 2026.
PRESS-RELEASE — Impact 2/10
Jul 10, 2026 Insider
Joerg Ingrid surrendered for taxes 2,984 shares
CEO @ $29.28 ($87.4K)
Jun 4, 2026 Insider
May 26, 2026 SEC Ormerod John sold 8,000 shares
Director @ $35.01 ($280.1K)
Constellium reported Q1 2026 EPS of $1.42, a 76% beat vs the $0.81 consensus, with revenue at $2.31B (in line). The mass
PRESS-RELEASE — Impact 7/10
Mixed insider cluster at CSTM over the past 7 days. A director made a $85K open-market purchase, while four senior execu
CLUSTER — Impact 3/10
Analyst ratings buy % +2.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
82% rate it Buy or better · 11 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 18, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Jul 30, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Jul 9, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Jul 8, 2026 | UBS | MAINTAIN | Buy | 55% |
| May 5, 2026 | UBS | INITIATE | Buy | 55% |
| Apr 30, 2026 | JP Morgan | DOWNGRADE | Neutral | 55% |
| Apr 30, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Apr 16, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Apr 16, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Feb 19, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Aug 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Jul 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Jun 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Apr 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Mar 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Feb 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% |
Price targets
Where 5 covering analysts think CSTM trades over the next 12 months.
$35.51 +45.6% upside Strong Buy
Current$24.40 Low$32.80 Median$35.64 High$38.58 5 analysts
$32.80$38.58
Analyst rating Strong Buy· 1.4/5 as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 3 bullish, 3 bearish, 0 mixed, 14 neutral · avg impact 4.5/10.
NEUTRALPRESS-RELEASE2/10
Constellium SE filed a press release announcing a conference call for its Q2 2026 earnings, schedule
Jul 10, 2026
BULLISHPRESS-RELEASE7/10
Constellium reported Q1 2026 EPS of $1.42, a 76% beat vs the $0.81 consensus, with revenue at $2.31B
May 26, 2026
NEUTRALCLUSTER3/10
Mixed insider cluster at CSTM over the past 7 days. A director made a $85K open-market purchase, whi
May 18, 2026
NEUTRALCLUSTER3/10
Five Constellium insiders, including the CFO and a director, sold a total of $2.25M in open-market s
May 13, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 1, 2026
short_volume
Short Volume: CSTM — 55.8% short (0.3M / 0.6M)
Short: 316,558 | Exempt: 200 | TRF Vol: 567,557 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Aug 21, 2026
short_volume
Short Volume: CSTM — 63.0% short (0.4M / 0.7M)
Short: 449,544 | Exempt: 559 | TRF Vol: 713,418 | Short Ratio: 63.0% | Off-exchange volume (dark pool + OTC)
Jul 29, 2026
earnings
Constellium Reports Strong Second Quarter and First Half 2026 Results, including Record Segment Adjusted EBITDA; Raises Full Year 2026 Guidance
PARIS, July 29, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the second quarter an
Jul 29, 2026
earnings_calendar
CSTM Q2 2026 Earnings Before Market Open — 2026-07-29
Jul 10, 2026
earnings
Constellium to Report Second Quarter 2026 Results on July 29, 2026
PARIS, July 10, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) will host a conference call and webcast on Wednesday, July 29, 2026, at 10:00 AM
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Next FY | $2.41 | $2.26–$2.55 | -34.3% | -4.8% | 1↑ 0↓ | $9.0B | 2 |
| Next Q | $0.47 | $0.45–$0.48 | -31.2% | +8.5% | 3↑ 1↓ | $2.2B | 3 |
| Current FY | $3.66 | $3.31–$4.01 | 150.8% | +22.8% | 1↑ 1↓ | $9.0B | 2 |
| Current Q | $0.64 | $0.63–$0.65 | 34.2% | +19.7% | 1↑ 1↓ | $2.3B | 2 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.640 | — |
| 7d ago | $0.544 | +0.096 |
| 30d ago | $0.535 | +0.105 |
| 60d ago | $0.535 | +0.105 |
| 90d ago | $0.535 | +0.105 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 50 transactions. Net -$11.5M — $207.7K bought, $11.7M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Deslarzes Jean-Christophe | Director | BUY | 1,490 | $27.24 | $40.6K |
| Jul 10, 2026 | Joerg Ingrid | CEO | TAX W/H | 2,984 | $29.28 | $87.4K |
| Jun 4, 2026 | Ormerod John | Director | SELL | 8,000 | $35.01 | $280.1K |
| May 28, 2026 | Becker Marcus | SVP CPO | SELL | 10,391 | $34.93 | $363.0K |
| May 14, 2026 | Jarrett Martin | SVP Chief Innovation Officer | SELL | 4,716 | $33.46 | $157.8K |
| May 14, 2026 | Soultz Bradley Lee | Director | BUY | 2,500 | $33.84 | $84.6K |
| May 12, 2026 | Piquier Ludovic | SVP Manuf Excellence & CTO | SELL | 1,000 | $33.57 | $33.6K |
| May 11, 2026 | Brun Nicolas | SVP PA, Comm & Sust | SELL | 26,661 | $33.85 | $902.5K |
| May 8, 2026 | Corre Stephane | President, AS&I | SELL | 5,000 | $33.52 | $167.6K |
| May 5, 2026 | Guo Jack Q. | EVP & CFO | SELL | 25,201 | $32.62 | $822.1K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CSTM.
Shares short
7,108,976
Settlement Sep 15, 2026
Change vs prior
+2.5%
Semi-monthly cycle
Days to cover
5.5
At avg daily volume
Of shares outstanding
≈5.3%
Estimate — not % of float
All CSTM filing & press-release reports (21)
- PRESS-RELEASE reportJul 10, 2026
- PRESS-RELEASE reportMay 26, 2026
- CLUSTER reportMay 18, 2026
- CLUSTER reportMay 13, 2026
- CLUSTER reportMay 12, 2026
- CLUSTER reportMay 7, 2026
- CLUSTER reportMay 7, 2026
- CLUSTER reportMay 5, 2026
- CLUSTER reportMay 4, 2026
- PRESS-RELEASE reportApr 29, 2026
- PRESS-RELEASE reportApr 15, 2026
- DEFA14A reportApr 10, 2026
- CLUSTER reportMar 17, 2026
- CLUSTER reportMar 17, 2026
- CLUSTER reportMar 16, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 11, 2026
- CLUSTER reportMar 11, 2026
- CLUSTER reportMar 11, 2026
- CLUSTER reportMar 6, 2026
- CLUSTER reportMar 3, 2026